Vaishali Sanchorawala

Boston University School of Medicine

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (18)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (5)

Giampaolo Merlini

University of Pavia

ITALY

View details

Deepa M. Gopal

UNITED STATES

View details

Hamza Hassan

Boston University

UNITED STATES

View details

Ashish Verma

Assistant Professor of Medicine

Boston University School of Medicine

UNITED STATES

View details

Adam Cohen

Associate Professor, Clinician-Educator

University of Pennsylvania

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Vaishali Sanchorawala

Research Interests

Explore related searches

Contact this professor

Articles (18)

Long‐term outcomes of renal AL amyloidosis patients undergoing autologous stem cell transplantation: Validating the performance of the renal staging system

Defying the Odds: 30 Years in AL Amyloidosis Research, Recent Barriers to Clinical Trial Enrollment

Factors impeding organ recovery despite a deep haematological response in patients with systemic AL amyloidosis

Machine‐learning based subgroups of AL amyloidosis and cumulative incidence of mortality and end stage kidney disease

Systemic AL Amyloidosis in Patients Younger Than 40 Years of Age: Clinical Presentation and Outcomes

The clinical trials landscape in immunoglobulin light chain amyloidosis: a systematic review

Systemic Light Chain Amyloidosis

Neurofilament light chain kinetics as a biomarker for polyneuropathy in V122I hereditary transthyretin amyloidosis

Birtamimab plus standard of care in light chain amyloidosis: the phase 3 randomized placebo-controlled VITAL trial

Predictors of treatment response and survival outcomes in patients with advanced cardiac AL amyloidosis

Factors affecting the accuracy of amyloidosis identification and referral to a specialty centre

Evaluating the Amyloidosis Speakers Bureau: the influence of amyloidosis patients’ narratives on medical students’ knowledge, attitudes, and behavioral intent

Hereditary gelsolin amyloidosis: a rare cause of cranial, peripheral and autonomic neuropathies linked to D187N and Y447H substitutions

Eureka Moment—Innovation Comes of an Age in Light Chain Amyloidosis

Health-Related Quality of Life Instruments for Clinical Trials in AL Amyloidosis: Report from the Amyloidosis Forum HRQOL Working Group

Quality of life and symptoms among patients with relapsed/refractory AL amyloidosis treated with ixazomib‐dexamethasone versus physician's choice

Non-producer multiple myeloma presenting with acute hyperammonemic encephalopathy: case report

Guidelines for non-transplant chemotherapy for treatment of systemic AL amyloidosis: EHA-ISA working group

Collaborators (5)

Giampaolo Merlini

Deepa M. Gopal

Hamza Hassan

Ashish Verma

Adam Cohen

Make your next move.